Skip to content

Effect of a lower limb strength training program on physical functioning in children with cerebral palsy

Effect of a lower limb strength training program on physical functioning in children with cerebral palsy - Popeye-onderzoek

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31736
Enrollment
50
Registered
2007-07-23
Start date
2007-08-20
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spastic children Spastic diplegia and hemiplegia

Interventions

The group training program will be based on an existing individual training program for children with CP and will be further developed according to current guidelines for strength training in childr

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children with spastic hemiplegia and diplegia, with GMFCS levels I, II and III (ambulant with and without aids, Palissano 1997) and aged from 6 to 13 years, will participate.

Exclusion criteria

Exclusion criteria: Children will be excluded if they have instable seizures, if they received (surgical) treatment for spasticity or surgical procedures up to 4 months prior to the study (or planned in the study period), if there is an expected change in medication during the study period, or if they suffer of other diseases that interfere with physical activity (judged by the physician).

Design outcomes

Primary

MeasureTime frame
Physical functioning is evaluated using the Gross Motor Function Measure, functional tests, walking ability, and a mobility questionnaire.

Secondary

MeasureTime frame
Muscle strength of the lower limbs is tested using hand held dynamometry and functional tests, and spasticity is determined with the spasticity test, based on the modified Tardieu scale.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)